Table 1.
Clinicopathologic characteristics of all 26 patients
| Characteristics | No of patient | % |
|---|---|---|
| Age, median = 63.4 (36.4-74.1) | ||
| 30- 60 | 10 | 38.5% |
| > 60 | 16 | 61.5% |
| Sex (n = 26) | ||
| Male | 22 | 84.6% |
| Female | 4 | 12.5% |
| Stage at diagnosis (n = 26) | ||
| Stage IB | 3 | 11.5% |
| Stage II | 6 | 23.1% |
| Stage III | 7 | 26.9% |
| Stage IV | 10 | 38.5% |
| Endoscopic finding (n = 23) | ||
| Borrmann type I | 2 | 8.7% |
| Borrmann type II | 5 | 21.7% |
| Borrmann type III | 11 | 47.8% |
| Borrmann type IV | 1 | 4.3% |
| EGC† | 4 | 17.4% |
| Location (n = 25) | ||
| Upper-third | 2 | 8.0% |
| Middle-third | 5 | 20.0% |
| Lower-third | 16 | 64.0% |
| Whole stomach | 2 | 8.0% |
| Immunohitstochemical staining (n = 26) | ||
| AFP (positive/negative/‡NA) | 15/4/7 | |
| Anti-hepatocyte (positive/negative/‡NA) | 4/4/18 | |
| Anti-chymotrypsin (positive/negative/‡NA) | 1/1/24 | |
| Serum AFP (n = 26) | ||
| Elevated (median, range) | 7 ( 208 ng/ml, 5-4,750,000 ng/ml) |
|
| Normal | 4 | |
| ‡NA | 15 |
† Early gastric cancer type, ‡Not assessed